Familial associations of lymphoma and myeloma with autoimmune diseases - Top-Institutions - MDSpire

Familial associations of lymphoma and myeloma with autoimmune diseases

  • By

  • K Hemminki

  • A Försti

  • K Sundquist

  • J Sundquist

  • X Li

  • January 6, 2017

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Immunology
    • Genetics
    • Epidemiology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Immunogenetics
    • Translational Research

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Epidemiology
    • Genetics
    • Autoimmune Diseases
    • Hematology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Immunology
    • Genomic Medicine

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology-Oncology
    • Immunogenetics
    • Autoimmune Disease Research

Original Source(s)

Familial associations of lymphoma and myeloma with autoimmune diseases

  • by K Hemminki, A Försti, K Sundquist, J Sundquist, X Li

  • January 6, 2017

Related Content

Infection risk associated with teclistamab in relapsed/refractory multiple myeloma: a systematic review and meta-analysis of clinical trial and real-world evidence

Case Report: Cytoreductive surgery as a therapeutic attempt in the treatment of extramedullary plasmacytoma

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.